Cargando…

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies

Benign prostatic hyperplasia (BPH) has been suggested to be a risk factor for certain urologic cancers, but the current evidence is inconsistent. The aim of this study was to investigate the association between BPH and urologic cancers. MEDLINE, EMBASE, Cochrane Library, and Web of Science were sear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xiaoyu, Fang, Xiangming, Ma, Ying, Xianyu, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	7300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863764/ https://www.ncbi.nlm.nih.gov/pubmed/27149447 http://dx.doi.org/10.1097/MD.0000000000003493

Ejemplares similares

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies
por: Xu, Huan, et al.
Publicado: (2016)

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men
por: Han, Zihua, et al.
Publicado: (2017)

Observation of complications assessed by Clavien-Dindo classification in different endoscopic procedures of benign prostatic hyperplasia: An observational study
por: Pan, Ting-ting, et al.
Publicado: (2023)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis
por: Su, Shunye, et al.
Publicado: (2020)

Analysis of the relationship between asthma and benign prostatic hyperplasia: A STROBE-compliant study
por: Wee, Jee Hye, et al.
Publicado: (2021)

Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2015)

Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis
por: Miller, Larry E., et al.
Publicado: (2020)

Transurethral 1470 nm diode laser vaporization versus plasma kinetic enucleation of the prostate for the treatment of benign prostatic hyperplasia: A retrospective study
por: Huang, Jiaguo, et al.
Publicado: (2023)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Feasibility of anterior lobe-preserving transurethral enucleation and resection of prostate on improving urinary incontinence in patients with benign prostatic hyperplasia: A retrospective cohort study
por: Huang, Xin, et al.
Publicado: (2023)

Effect of transurethral split of the prostate using a double-columnar balloon catheter for benign prostatic hyperplasia: A single-center experience of 565 consecutive patients
por: Huang, Weiguo, et al.
Publicado: (2016)

The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis
por: Li, Zhuo, et al.
Publicado: (2016)

Endoscopic enucleation vs endoscopic vaporization procedures for benign prostatic hyperplasia: how should we choose: A protocol for systematic review and meta-analysis
por: Yin, Xinbao, et al.
Publicado: (2020)

Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population
por: Park, Jee Soo, et al.
Publicado: (2019)

Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan
por: Obinata, Daisuke, et al.
Publicado: (2023)

To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: A protocol for systematic review and meta analysis
por: Ma, Chengquan, et al.
Publicado: (2020)

The first case of bipolar transurethral resection of the prostate for giant prostatic hyperplasia: A case report
por: Cui, Deheng, et al.
Publicado: (2022)

Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis
por: Guo, Jianming, et al.
Publicado: (2021)

Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
por: Chen, Ping, et al.
Publicado: (2015)

Exploring the mechanism of action of Qian Lie Xing Fang during the treatment of benign prostatic hyperplasia via network pharmacology and molecular dynamics simulation analyses
por: Xiang, Jingjing, et al.
Publicado: (2023)

Green tea and the risk of prostate cancer: A systematic review and meta-analysis
por: Guo, Yuming, et al.
Publicado: (2017)

Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)

Prostate tuberculosis mimicking prostate cancer: Case report and literature review
por: Li, Yu, et al.
Publicado: (2023)

Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis
por: Cui, Zhigang, et al.
Publicado: (2017)

ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis
por: Chang, Xueliang, et al.
Publicado: (2023)

Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial
por: Song, Jungbin, et al.
Publicado: (2019)

Association of 17q24 rs1859962 gene polymorphism with prostate cancer risk: A systematic review and meta-analysis
por: Ren, Feiqiang, et al.
Publicado: (2020)

Shift work, night work, and the risk of prostate cancer: A meta-analysis based on 9 cohort studies
por: Du, Hong-Bing, et al.
Publicado: (2017)

Prognostic value of the miR-200 family in bladder cancer: A systematic review and meta-analysis
por: Mei, Yanhui, et al.
Publicado: (2020)

Based on biomedical index data: Risk prediction model for prostate cancer
por: Guo, Hanxu, et al.
Publicado: (2021)

Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis
por: Zhang, Ming, et al.
Publicado: (2022)

The association between sleep duration and prostate cancer: A systematic review and meta-analysis
por: Liu, Ranlu, et al.
Publicado: (2020)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysis
por: Yin, Xiaotao, et al.
Publicado: (2016)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis
por: Liu, Jinnian, et al.
Publicado: (2021)

The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021)

Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_brfu6ljr0i383k4q8kthplibma